Pfizer Inc. said Tuesday that a COVID-19 vaccine that specifically targets the Omicron variant will be ready by March. The company has already started making the new version of the vaccine, Pfizer CEO Albert Bourla told CNBC‘s “Squawk Box,” CBS News reported. Omicron now accounts for more than 98% of all new COVID-19 cases in…  read on >  read on >

For several years, a leading U.S. pediatricians’ group has called for middle and high schools to start later in the morning, to help these young people get the right amount of sleep. Now, new research suggests that students aren’t the only ones who benefit from later start times: Their parents also catch a break. “Kids…  read on >  read on >

Parents, brace yourselves. As the Omicron variant surges and U.S. schools deal with a substitute teacher shortage and related pandemic fallout, don’t be surprised if a return to remote or hybrid learning leads your kids to act out, a new study warns. Previous shifts from in-person to remote or hybrid learning (a combination of the…  read on >  read on >

The United States has passed another grim milestone in the pandemic as the Omicron variant races across the country: COVID hospitalizations have now eclipsed a previous peak, which was seen last January. There were 142,388 people hospitalized with COVID-19 as of Sunday, more than the previous record of 142,315 hospitalizations reported on Jan. 14, 2021,…  read on >  read on >

TUESDAY, Jan. 11, 2022 –Men who are broken-hearted or just unlucky in love could be more likely to have health-damaging inflammation, new research suggests. Serious breakups and solo living for many years may increase the risk of ill health and death — but apparently only for men, according to the researchers behind a new Danish…  read on >  read on >

Examining a woman’s health in midlife can predict her health decades later, researchers say. Four specific factors — higher body mass index (BMI), smoking, arthritis and depressive symptoms — at age 55 are associated with clinically important declines in physical health 10 years later, a new study reports. “Age 55 to 65 may be a…  read on >  read on >

Medicare has been told to reassess a significant premium increase it had announced that largely stemmed from the expensive new Alzheimer’s drug Aduhelm. U.S. Health and Human Services Secretary Xavier Becerra’s directive, which was announced on Monday, comes shortly after Aduhelm maker Biogen cut the price of the drug by about half, from $56,000 to…  read on >  read on >